Bagalanon, Baby Boy .

HRN: 22-17-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
11/06/2022
11/12/2022
IV
6mg
OD
Neonatal Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: